Ann Orr
Impact in
- Virology top 5%
- HIV Research and Treatment
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
Papers in ⓘ
- Virology 3
- HIV Research and Treatment 3
-
- HIV/AIDS drug development and treatment 5
- Co-authors
- Yves Pommier (9 shared papers)Kurt W. Kohn (5 shared papers)Giovanni Capranico (2 shared papers)Nouri Neamati (4 shared papers)Jean‐François Riou (1 shared paper)Jim A. Turpin (2 shared papers)Duane R. Pilch (2 shared papers)Christopher L. Hatch (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (3 papers)Bioorganic & Medicinal Chemistry (2 papers)Molecular and Cellular Biology (2 papers)Antiviral chemistry & chemotherapy (1 paper)Journal of Molecular Biology (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Ann Orr
16 papers receiving 596 citations
Peers
Comparison fields: 5 of 65
- Virology 120
- Toxicology 78
- Infectious Diseases 163
- Organic Chemistry 219
- Molecular Biology 431
Countries citing papers authored by Ann Orr
This map shows the geographic impact of Ann Orr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Orr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Orr more than expected).
Fields of papers citing papers by Ann Orr
This network shows the impact of papers produced by Ann Orr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Orr. The network helps show where Ann Orr may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann Orr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 111 | |
| 2 | 1999 | 77 | |
| 3 | Rational design and molecular effects of a new topoisomerase II inhibitor, azatoxin. | 1992 | 65 |
| 4 | 2002 | 63 | |
| 5 | 1991 | 60 | |
| 6 | Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene. | 1992 | 45 |
| 7 | 2001 | 42 | |
| 8 | 1998 | 42 | |
| 9 | 1993 | 31 | |
| 10 | 2000 | 26 | |
| 11 | 1993 | 19 | |
| 12 | 1994 | 18 | |
| 13 | "Waterbug" dialysis. | 1995 | 4 |
| 14 | 2019 | 2 | |
| 15 | 1994 | 2 | |
| 16 | 1980 | 2 | |
| 17 | 1994 | 0 |
About Ann Orr
Ann Orr is a scholar working on Virology, Infectious Diseases, Molecular Biology, Microbiology and Organic Chemistry, having authored 17 papers that have together received 609 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), HIV/AIDS drug development and treatment (5 papers), DNA and Nucleic Acid Chemistry (4 papers), HIV Research and Treatment (3 papers), Biochemical and Molecular Research (3 papers), Synthesis and Biological Evaluation (2 papers), Genomics and Chromatin Dynamics (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Virology (120 citations), Toxicology (78 citations), Infectious Diseases (163 citations), Organic Chemistry (219 citations) and Molecular Biology (431 citations). Ann Orr has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Yves Pommier, Kurt W. Kohn, Giovanni Capranico, Nouri Neamati, Jean‐François Riou, Jim A. Turpin, Duane R. Pilch, Christopher L. Hatch, Cecilia Mannironi and William M. Bonner. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Molecular and Cellular Biology, Antiviral chemistry & chemotherapy and Journal of Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.